Distribution of KIR/HLA alleles among ethnic Han Chinese patients with hepatocellular carcinoma from southern China.
10.3760/cma.j.issn.1003-9406.2019.05.006
- Author:
Suqing GAO
1
;
Baihai JIAO
;
Wenxu HONG
;
Chuangchuang CAI
;
Yanping ZHONG
;
Zhanrou QUAN
;
Hao CHEN
;
Yunping XU
Author Information
1. Institute of Blood Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong 518035, China. Email: xuyunping1982@163.com.
- Publication Type:Journal Article
- MeSH:
Alleles;
Carcinoma, Hepatocellular;
genetics;
China;
Gene Frequency;
Genotype;
Humans;
Liver Neoplasms;
genetics;
Polymorphism, Genetic;
Receptors, KIR
- From:
Chinese Journal of Medical Genetics
2019;36(5):439-442
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To assess the association of KIR/HLA alleles with hepatocellular carcinoma (HCC) and hepatitis B virus (HBV) infection among ethnic Han Chinese patients from southern China.
METHODS:For 95 patients with HCC and 171 healthy controls, the genotype of HLA-C alleles was determined with a PCR sequence-specific oligonucleotides typing method on an Illumina GenDx NGSgo platform. Genotypes comprised of HLA-C and KIR gene alleles were also subjected to statistical analysis.
RESULTS:In total 16 KIR genes (2DL2, 2DS2, 2DS3, 2DS5, 3DS1, 2DS1, 2DL5, 2DS4, 3DL1, 3DP1, 2DL3, 2DP1, 3DL3, 2DL1, 3DL2 and 2DL4) were discovered in the two groups. The frequencies of KIR2DL3 alleles and combinational genotypes of KIR2DL3/HLA-C1C2 were significantly lower in the patient group compared with the controls (0.9368 vs. 0.9883, χ²>3.84; P<0.05, OR = 0.1; 0.0112 vs. 0.2663, χ²>3.84; P<0.05, RR = 0.03). The frequency of HLA-C2C2 genotype of the patient group was significantly lower than that of the controls (0.0316 vs. 0.2690, P<0.05, RR = 0.09), while the frequency of HLA-C1C2 genotype was significantly higher than that of the controls (0.2316 vs. 0.0058, P<0.05, RR = 51.23).
CONCLUSION:Above results suggested that the KIR2DL3 allele is associated with lower risk for HCC. There may be individual difference in patients with HCC and HBV infection but various combinations of KIR/HLA alleles.
